Source: Marketscreener

Haemonetics: Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

BOSTON , Jan. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 5:15 pm Pacific Time . The public may access Mr. Simon's presentation live via audio webcast at: https://jpmorgan.metameetings.net/events/healthcare25/sessions/58190-haemonetics-corporation/webcast?gpu_only=true&kiosk=true The live webcast can also be accessed under the Events & Presentations section of Haemonetics' Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Haemonetics' Investor Relations website beginning approximately one hour after completion of the live event. ABOUT HAEMONETICS Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com . Investor Contacts: Olga Guyette, Vice President-Investor Relations & Treasury David Trenk, Manager-Investor Relations (781) 356-9763 (203) 733-4987 olga.guyette@haemonetics.com david.trenk@haemonetics.com Media Contact: Josh Gitelson, Sr. Director-Global Communications (781) 356-9776 josh.gitelson@haemonetics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/haemonetics-to-present-at-43rd-annual-jp-morgan-healthcare-conference-302342258.html SOURCE Haemonetics Corporation BOSTON , Jan. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon , President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 5:15 pm Pacific Time . The public may access Mr. Simon's presentation live via audio webcast at: https://jpmorgan.metameetings.net/events/healthcare25/sessions/58190-haemonetics-corporation/webcast?gpu_only=true&kiosk=true The live webcast can also be accessed under the Events & Presentations section of Haemonetics' Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Haemonetics' Investor Relations website beginning approximately one hour after completion of the live event. ABOUT HAEMONETICS Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com . Investor Contacts: Olga Guyette, Vice President-Investor Relations & Treasury David Trenk, Manager-Investor Relations (781) 356-9763 (203) 733-4987 olga.guyette@haemonetics.com david.trenk@haemonetics.com Media Contact: Josh Gitelson, Sr. Director-Global Communications (781) 356-9776 josh.gitelson@haemonetics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/haemonetics-to-present-at-43rd-annual-jp-morgan-healthcare-conference-302342258.html SOURCE Haemonetics Corporation

Read full article »
Annual Revenue
$1.0-5.0B
Employees
1.0-5.0K
Christopher Simon's photo - President & CEO of Haemonetics

President & CEO

Christopher Simon

CEO Approval Rating

96/100

Read more